| Literature DB >> 25059420 |
Sabine Herget1, Almut Rudolph, Anja Hilbert, Susann Blüher.
Abstract
OBJECTIVE: As long-term results of conservative treatment for obesity are discouraging, bariatric surgery is becoming a treatment option for extremely obese adolescents. However, mental and behavioral problems need to be respected when treating this vulnerable target group.Entities:
Mesh:
Year: 2014 PMID: 25059420 PMCID: PMC5644788 DOI: 10.1159/000365793
Source DB: PubMed Journal: Obes Facts ISSN: 1662-4025 Impact factor: 3.942
Fig. 1Flowchart of literature search performed. Articles found and selected for review using PsychINFO, Pubmed and Medline electronic databases.
Studies addressing psychopathology in adolescent patients (depressive disorder symptoms, anxiety and eating disorder symptoms] before undergoing bariatric surgery
| Study | Sample | Study design and surgical procedure | Method | Prevalence (%) and severity |
|---|---|---|---|---|
|
| ||||
| Duffecy et al., 2008 [ | N = 40; age = 15 years; BMI = 50 kg/m2; 60% female; USA | retrospective review psychological data LAGB | BDI (clinical interview) | 32%: moderate to severe depressive symptoms (BDI) |
| Kim et al., 2008 [ | N = 25; age =18.8 ± 1.5 years; BMI = 50.6 kg/m2; 76% female; USA | review of clinical charts procedure not specified | BDI-II (clinical interview) | mean BDI = 10.4 ± 10.4 68% of sample: clinical depression |
| Ratcliff et al., 2011 [ | N = 30; age = 16.5 ± 1.4 years; BMI = 64.5 kg/m2; 60% female; USA | retrospective chart review prospective, controlled longitudinal study RYGB | BDI-II | 47%: minimal depressive symptoms |
| Zeller et al., 2006 [ | N = 33; age =16.3 ± 1.2 years; BMI = 58.8 kg/m2; 55% female; USA | retrospective review clinical data procedure not specified | BDI-II | 52%: minimal depressive symptoms |
|
| ||||
|
| ||||
| Duffecy et al., 2008 [ | N = 40; Age = 15 years; BMI = 50 kg/m2; 60% female; USA | retrospective review psychological data LAGB | clinical interview | 25% anxiety disorder symptoms |
| Jarvholm et al 2012 [ | N = 35; BMI = 46.5 kg/m2; age = 16.6 ± 1.3 years; 67.6% female; Sweden | prospective feasibility and safety study RYGB | BYI | 22%: score ≥ 90th percentile (highly elevated) anxiety disorder symptoms 43%: score ≥ 75th percentile (average range) anxiety disorder symptoms |
| Kim et al., 2008 [ | N = 25; BMI = 50.6 kg/m2; age = 18.8 ± 1.5 years; 76% female; USA | review of clinical charts procedure not specified | clinical interview | 18% history of anxiety disorder symptoms |
|
| ||||
|
| ||||
| Kim et al., 2008 [ | N = 25; age = 18.8 ± 1.5 years; BMI = 50.6 kg/m2; 76% female; USA | review of clinical charts procedure not specified | WALI | 48%: eating large amounts of food in 2 h |
| Widhalm et al., 2008 [ | N = 10; age = 17.3 ± 3 years; BMI = 49.1 kg/m2; 30% female; Austria | clinical follow-up of patients LAGB | EWI | 70%: emotional eating over life course |
BDI = Beck Depression Inventory; BYI = Beck Youth Inventory; WALI = Weight and Lifestyle Inventory; EWI = Eating Behavior and Weight Problems Inventory for Children; LAGB = laparoscopic adjustable gastric banding; RYGB= Roux-en-Y gastric bypass.
Studies addressing depressive disorder symptoms in adolescent patients after undergoing bariatric surgery
| Study | Sample | Study design, follow-up, and surgical procedure | Method | Percentage/severity T0 | Percentage/severity T1 | Δ change in clinical depressive symptoms | |
|---|---|---|---|---|---|---|---|
| Cozacov et al., 2014 [ | N = 18; age = 17.5 years; BMI = 47.2 kg/m2; 72.2% female; USA | retrospective review of prospectively collected data 12 months RYGB, LSG | ? | 22 % clinical depression | 5.5% clinical depression | −75% clinical depression (−100 % clinical depression] | |
| Holterman et al., 2007 [ | N = 10, age = 16 ± 0.8 years; BMI = 50 ± 13 kg/m2; 100% female; USA | clinical follow-up 9 months LAGB | BDI-II | 30%: severe depressive symptoms mean BDI = 11 ± 8 | 30%: mild/ minimal depressive symptoms mean BDI = 2.2 ± 2.7 BDI 6 months: 5.4 ± 6.2 BDI 3 months: 9.8 ± 10.5 | −100% clinical depressive symptoms BDI reduction: −80% | |
| Jarvholm et al., 2012 [ | N = 37; age =16.6 ± 1.6 years; BMI = 46.5 kg/m2; 67.6% female; Sweden | prospective feasibility and safety study 6 months RYGB | BYI BDI-II | 49% score ≥ 75th percentile (average range] 27%: score ≥ 90th percentile (highly elevated] | 68% ≥ 75th percentile (average range] 11% score ≥ 90th percentile (highly elevated] | −60.3% clinical depressive symptoms | |
| Osorio et al., 2011 [ | N = 14; age = 16 ± 1.3 years; BMI = 46.1 ± 3.1 kg/m2; 71.4% female; Portugal | prospective study 9 years LAGB | BDI? | 28%: severe depressive symptoms | 21%: severe depressive symptoms (reactive depressive symptoms] | −25% clinical depressive symptoms | |
| Sysko et al., 2012 [ | N = 101; age = 15.8 ± 1.1 years; BMI = 47.2 ± 0.9 kg m2; 72.3% female; USA | prospective study 1 year LAGB | BDI clinical interview | minimal depressive symptoms mean BDI = 7.5 ± 1.1 | BDI 1 month: 6.7 ± 1.2 | clinical range depressive symptoms not documented BDI reduction: −37.1% | |
| Zeller et al., 2009 [ | N = 31; age =16.4 ± 1.4 years; BMI = 63.5 ± 10.6 kg/ m2; 64.5% female; USA | prospective study 1 year RYGB | BDI-II | 38.7%: clinical range depressive symptoms mean BDI = 15.2 ± 12.4 | 6.9%: clinical range depressive symptoms BDI 6 months = 7.3 ± 9.0 | −75% clinical depressive symptoms BDI reduction: −65.1% | |
| Zeller et al., 2011 [ | N = 16; age = 16.2. years; BMI = 59.9 ± 3.1 kg/m2; 62.5% female; USA | prospective observational study 2 years RYGB | BDI-II | 62.5%: clinical elevated depressive symptoms mean BDI = 7.7 ± 9.7 | 14.3%: clinical range depressive symptoms | BDI 6 months = 8.6 ± 11.5 | −77.2% clinical depressive symptoms 2011 BDI reduction: 62.4% |
BDI = Beck Depression Inventory; BYI = Beck Youth Inventory; WALI = Weight and Lifestyle Inventory, EWI = Eating Behaviour and Weight Problems Inventory for Children; LAGB = laparoscopic adjustable gastric banding; RYGB= Roux-en-Y gastric bypass; LSG = laparoscopic sleeve gastrectomy.